世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

マイクロフィジオロジー・システム - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030


Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

マイクロフィジオロジーシステムの世界市場規模は、2023年に1億892万米ドルと推定され、予測期間2024-2030年のCAGRは30.3%で、2030年には7億619万米ドルに再調整されると予測されている。 マイクロフィジオロジ... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2024年9月13日 US$3,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

マイクロフィジオロジーシステムの世界市場規模は、2023年に1億892万米ドルと推定され、予測期間2024-2030年のCAGRは30.3%で、2030年には7億619万米ドルに再調整されると予測されている。
マイクロフィジオロジーシステムの北米市場は、2023年に4,754万ドルと評価され、2024年から2030年の予測期間中に31.4％のCAGRで、2030年までに3億2,531万ドルに達すると予測されています。
微小生理システムのアジア太平洋市場は、2023年に1,264万ドルと評価され、2024年から2030年の予測期間中に30.0％のCAGRで、2030年までに8,105万ドルに達するだろう。
微小生理システムのヨーロッパ市場は、2023年に4,491万ドルと評価され、2024年から2030年の予測期間中に29.3％のCAGRで、2030年までに2億7,672万ドルに達するだろう。

マイクロフィジオロジーシステムの世界の主要企業には、Emulate、Mimetas、InSphero、TissUse、CN Bio、Hesperos、Valo Health（TARA Biosystems）、TNO、AxoSim、Newcells Biotechなどが含まれる。2023年には、世界の大手5社が売上高で約50.59％のシェアを占めている。
本レポートは、Microphysiological Systemの世界市場について、地域別・国別、タイプ別、エンドユーザー別の分析とともに、総売上高、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。
マイクロフィジオロジーシステムの市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを売上高（百万ドル）で提供しています。定量的および定性的な分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場での地位を分析し、Microphysiological Systemに関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。

市場区分

企業別
エミュレート
ミメタス
インスフェロ
TissUse
CNバイオ
ヘスペロス
ヴァローヘルス（TARAバイオシステムズ）
TNO
アクソシム
ニューセルズバイオテック
ノーティス
ネトリ
ドレイパー研究所
北京大翔バイオテック
アルティスバイオシステムズ
チェリーバイオテック
Bi/ond
オバタラ・サイエンシズ
アナンダ・デバイス
イミュワン
リアクトフォーライフ
肺胞X
バイオミックス
アラカリ・バイオ
ステムファーム
シンバイオ

タイプ別セグメント
ヒト臓器・組織モデル
疾患モデル
非ヒト種モデル

エンドユーザー別セグメント
製薬・バイオテクノロジー企業
学術・研究機関
その他

地域別
北米
米国
カナダ

アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア太平洋地域

欧州
ドイツ
フランス
英国
イタリア
オランダ
北欧諸国
その他のヨーロッパ諸国

ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ

中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の地域

各章の概要
第1章： レポートのスコープ、世界の総市場規模を紹介します。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。
第2章：マイクロフィジオロジーシステム企業の競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。
第3章：各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。
第4章：エンドユーザー別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場でブルーオーシャン市場を見つけるのを助ける。
第5章：地域レベルでのマイクロフィジオロジーシステムの収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見込み、市場スペース、市場規模を紹介しています。
第6章 マイクロフィジオロジーシステムの国別売上高各国/地域のタイプ別、エンドユーザー別のシグメイトデータを提供しています。
第7章：主要企業のプロフィールを提供し、製品収益、粗利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。
第8章：産業の上流と下流を含む産業チェーンの分析。
第9章：結論



ページTOPに戻る


目次

1 Market Overview 1
1.1 Microphysiological System Product Introduction 1
1.2 Global Microphysiological System Market Size Forecast (2019-2030) 2
1.3 Microphysiological System Market Trends & Drivers 3
1.3.1 Microphysiological System Industry Trends 3
1.3.2 Microphysiological System Market Drivers & Opportunity 4
1.3.3 Microphysiological System Market Challenges 6
1.3.4 Microphysiological System Market Restraints 7
1.4 Government Policy Support for The Industry 8
1.5 Comparison of Related Technologies 11
1.6 Assumptions and Limitations 12
1.7 Study Objectives 13
1.8 Years Considered 14
2 Competitive Analysis by Company 15
2.1 Global Microphysiological System Players Revenue Ranking (2023) 15
2.2 Global Microphysiological System Revenue by Company (2019-2024) 16
2.3 Key Companies Microphysiological System Headquarters and Sales Area 18
2.4 Key Companies Microphysiological System Product Offered 20
2.5 Establish Date of Global Key Microphysiological System Companies 21
2.6 Microphysiological System Market Competitive Analysis 22
2.6.1 Microphysiological System Market Concentration Rate (2019-2024) 22
2.6.2 Global 5 and 10 Largest Companies by Microphysiological System Revenue in 2023 23
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2023) 24
2.7 Mergers & Acquisitions, Expansion 25
3 Segmentation by Type 31
3.1 Introduction by Type 31
3.1.1 Human Organ and Tissue Models 31
3.1.2 Disease Models 33
3.1.3 Non-Human Species Models 34
3.2 Global Microphysiological System Sales Value by Type 35
3.2.1 Global Microphysiological System Sales Value by Type (2019 VS 2023 VS 2030) 36
3.2.2 Global Microphysiological System Sales Value, by Type (2019-2030) 38
3.2.3 Global Microphysiological System Sales Value, by Type (%) (2019-2030) 38
4 Segmentation by End User 40
4.1 Introduction by End User 40
4.1.1 Pharmaceutical & Biotechnology Companies 40
4.1.2 Academic & Research Institutes 42
4.1.3 Others 43
4.2 Global Microphysiological System Sales Value by End User 44
4.2.1 Global Microphysiological System Sales Value by End User (2019 VS 2023 VS 2030) 45
4.2.2 Global Microphysiological System Sales Value, by End User (2019-2030) 47
4.2.3 Global Microphysiological System Sales Value, by End User (%) (2019-2030) 47
5 Segmentation by Region 49
5.1 Global Microphysiological System Sales Value by Region 49
5.1.1 Global Microphysiological System Sales Value by Region: 2019 VS 2023 VS 2030 49
5.1.2 Global Microphysiological System Sales Value by Region (2019-2024) 49
5.1.3 Global Microphysiological System Sales Value by Region (2025-2030) 50
5.1.4 Global Microphysiological System Sales Value by Region (%), (2019-2030) 50
5.2 North America 52
5.2.1 North America Microphysiological System Sales Value, 2019-2030 52
5.2.2 North America Microphysiological System Sales Value by Country (%), 2023 VS 2030 53
5.3 Europe 54
5.3.1 Europe Microphysiological System Sales Value, 2019-2030 54
5.3.2 Europe Microphysiological System Sales Value by Country (%), 2023 VS 2030 55
5.4 Asia Pacific 56
5.4.1 Asia Pacific Microphysiological System Sales Value, 2019-2030 56
5.4.2 Asia Pacific Microphysiological System Sales Value by Region (%), 2023 VS 2030 57
5.5 Latin America 58
5.5.1 Latin America Microphysiological System Sales Value, 2019-2030 58
5.5.2 Latin America Microphysiological System Sales Value by Country (%), 2023 VS 2030 59
5.6 Middle East & Africa 60
5.6.1 Middle East & Africa Microphysiological System Sales Value, 2019-2030 60
5.6.2 Middle East & Africa Microphysiological System Sales Value by Country (%), 2023 VS 2030 61
6 Segmentation by Key Countries/Regions 62
6.1 Key Countries/Regions Microphysiological System Sales Value Growth Trends, 2019 VS 2023 VS 2030 62
6.2 Key Countries/Regions Microphysiological System Sales Value, 2019-2030 63
6.3 United States 66
6.3.1 United States Microphysiological System Sales Value, 2019-2030 66
6.3.2 United States Microphysiological System Sales Value by Type (%), 2023 VS 2030 67
6.3.3 United States Microphysiological System Sales Value by End User, 2023 VS 2030 68
6.4 Europe 69
6.4.1 Europe Microphysiological System Sales Value, 2019-2030 69
6.4.2 Europe Microphysiological System Sales Value by Type (%), 2023 VS 2030 70
6.4.3 Europe Microphysiological System Sales Value by End User, 2023 VS 2030 71
6.5 China 72
6.5.1 China Microphysiological System Sales Value, 2019-2030 72
6.5.2 China Microphysiological System Sales Value by Type (%), 2023 VS 2030 73
6.5.3 China Microphysiological System Sales Value by End User, 2023 VS 2030 74
6.6 Japan 75
6.6.1 Japan Microphysiological System Sales Value, 2019-2030 75
6.6.2 Japan Microphysiological System Sales Value by Type (%), 2023 VS 2030 76
6.6.3 Japan Microphysiological System Sales Value by End User, 2023 VS 2030 77
6.7 Southeast Asia 78
6.7.1 Southeast Asia Microphysiological System Sales Value, 2019-2030 78
6.7.2 Southeast Asia Microphysiological System Sales Value by Type (%), 2023 VS 2030 79
6.7.3 Southeast Asia Microphysiological System Sales Value by End User, 2023 VS 2030 80
6.8 France 81
6.8.1 France Microphysiological System Sales Value, 2019-2030 81
6.8.2 France Microphysiological System Sales Value by Type (%), 2023 VS 2030 82
6.8.3 France Microphysiological System Sales Value by End User, 2023 VS 2030 83
6.9 UK 84
6.9.1 UK Microphysiological System Sales Value, 2019-2030 84
6.9.2 UK Microphysiological System Sales Value by Type (%), 2023 VS 2030 85
6.9.3 UK Microphysiological System Sales Value by End User, 2023 VS 2030 86
7 Company Profiles 87
7.1 Emulate 87
7.1.1 Emulate Profile 87
7.1.2 Emulate Main Business 88
7.1.3 Emulate Microphysiological System Products, Services and Solutions 88
7.1.4 Emulate Microphysiological System Revenue (US$ Million) & (2019-2024) 89
7.2 Mimetas 90
7.2.1 Mimetas Profile 90
7.2.2 Mimetas Main Business 90
7.2.3 Mimetas Microphysiological System Products, Services and Solutions 91
7.2.4 Mimetas Microphysiological System Revenue (US$ Million) & (2019-2024) 93
7.2.5 Mimetas Recent Developments 93
7.3 InSphero 94
7.3.1 InSphero Profile 94
7.3.2 InSphero Main Business 95
7.3.3 InSphero Microphysiological System Products, Services and Solutions 95
7.3.4 InSphero Microphysiological System Revenue (US$ Million) & (2019-2024) 96
7.3.5 InSphero Recent Developments 96
7.4 TissUse 97
7.4.1 TissUse Profile 97
7.4.2 TissUse Main Business 98
7.4.3 TissUse Microphysiological System Products, Services and Solutions 98
7.4.4 TissUse Microphysiological System Revenue (US$ Million) & (2019-2024) 99
7.5 CN Bio 99
7.5.1 CN Bio Profile 99
7.5.2 CN Bio Main Business 100
7.5.3 CN Bio Microphysiological System Products, Services and Solutions 100
7.5.4 CN Bio Microphysiological System Revenue (US$ Million) & (2019-2024) 104
7.5.5 CN Bio Recent Developments 104
7.6 Hesperos 106
7.6.1 Hesperos Profile 106
7.6.2 Hesperos Main Business 107
7.6.3 Hesperos Microphysiological System Products, Services and Solutions 107
7.6.4 Hesperos Microphysiological System Revenue (US$ Million) & (2019-2024) 109
7.7 Valo Health (TARA Biosystems) 109
7.7.1 Valo Health (TARA Biosystems) Profile 109
7.7.2 Valo Health (TARA Biosystems) Main Business 110
7.7.3 Valo Health (TARA Biosystems) Microphysiological System Products, Services and Solutions 111
7.7.4 Valo Health (TARA Biosystems) Microphysiological System Revenue (US$ Million) & (2019-2024) 112
7.7.5 Valo Health (TARA Biosystems) Recent Developments 112
7.8 TNO 113
7.8.1 TNO Profile 113
7.8.2 TNO Main Business 114
7.8.3 TNO Microphysiological System Products, Services and Solutions 114
7.8.4 TNO Microphysiological System Revenue (US$ Million) & (2019-2024) 116
7.9 AxoSim 116
7.9.1 AxoSim Profile 116
7.9.2 AxoSim Main Business 117
7.9.3 AxoSim Microphysiological System Products, Services and Solutions 118
7.9.4 AxoSim Microphysiological System Revenue (US$ Million) & (2019-2024) 119
7.9.5 AxoSim Recent Developments 119
7.10 Newcells Biotech 120
7.10.1 Newcells Biotech Profile 120
7.10.2 Newcells Biotech Main Business 121
7.10.3 Newcells Biotech Microphysiological System Products, Services and Solutions 121
7.10.4 Newcells Biotech Microphysiological System Revenue (US$ Million) & (2019-2024) 122
7.10.5 Newcells Biotech Recent Developments 123
7.11 Nortis 124
7.11.1 Nortis Profile 124
7.11.2 Nortis Main Business 125
7.11.3 Nortis Microphysiological System Products, Services and Solutions 125
7.11.4 Nortis Microphysiological System Revenue (US$ Million) & (2019-2024) 127
7.11.5 Nortis Recent Developments 127
7.12 Netri 128
7.12.1 Netri Profile 128
7.12.2 Netri Main Business 129
7.12.3 Netri Microphysiological System Products, Services and Solutions 129
7.12.4 Netri Microphysiological System Revenue (US$ Million) & (2019-2024) 131
7.12.5 Netri Recent Developments 131
7.13 Draper Laboratory 132
7.13.1 Draper Laboratory Profile 132
7.13.2 Draper Laboratory Main Business 132
7.13.3 Draper Laboratory Microphysiological System Products, Services and Solutions 133
7.13.4 Draper Laboratory Microphysiological System Revenue (US$ Million) & (2019-2024) 138
7.14 Beijing Daxiang Biotech 138
7.14.1 Beijing Daxiang Biotech Profile 138
7.14.2 Beijing Daxiang Biotech Main Business 139
7.14.3 Beijing Daxiang Biotech Microphysiological System Products, Services and Solutions 140
7.14.4 Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million) & (2019-2024) 142
7.15 Altis Biosystems 142
7.15.1 Altis Biosystems Profile 142
7.15.2 Altis Biosystems Main Business 143
7.15.3 Altis Biosystems Microphysiological System Products, Services and Solutions 144
7.15.4 Altis Biosystems Microphysiological System Revenue (US$ Million) & (2019-2024) 145
7.15.5 Altis Biosystems Recent Developments 146
7.16 Cherry Biotech 146
7.16.1 Cherry Biotech Profile 146
7.16.2 Cherry Biotech Main Business 147
7.16.3 Cherry Biotech Microphysiological System Products, Services and Solutions 148
7.16.4 Cherry Biotech Microphysiological System Revenue (US$ Million) & (2019-2024) 149
7.17 Bi/ond 149
7.17.1 Bi/ond Profile 150
7.17.2 Bi/ond Main Business 150
7.17.3 Bi/ond Microphysiological System Products, Services and Solutions 151
7.17.4 Bi/ond Microphysiological System Revenue (US$ Million) & (2019-2024) 153
7.18 Obatala Sciences 154
7.18.1 Obatala Sciences Profile 154
7.18.2 Obatala Sciences Main Business 155
7.18.3 Obatala Sciences Microphysiological System Products, Services and Solutions 155
7.18.4 Obatala Sciences Microphysiological System Revenue (US$ Million) & (2019-2024) 157
7.19 Ananda Devices 157
7.19.1 Ananda Devices Profile 157
7.19.2 Ananda Devices Main Business 158
7.19.3 Ananda Devices Microphysiological System Products, Services and Solutions 159
7.19.4 Ananda Devices Microphysiological System Revenue (US$ Million) & (2019-2024) 161
7.19.5 Ananda Devices Recent Developments 161
7.20 ImmuONE 161
7.20.1 ImmuONE Profile 162
7.20.2 ImmuONE Main Business 162
7.20.3 ImmuONE Microphysiological System Products, Services and Solutions 163
7.20.4 ImmuONE Microphysiological System Revenue (US$ Million) & (2019-2024) 165
7.20.5 ImmuONE Recent Developments 165
7.21 React4life 166
7.21.1 React4life Profile 166
7.21.2 React4life Main Business 166
7.21.3 React4life Microphysiological System Products, Services and Solutions 167
7.21.4 React4life Microphysiological System Revenue (US$ Million) & (2019-2024) 169
7.22 AlveoliX 170
7.22.1 AlveoliX Profile 170
7.22.2 AlveoliX Main Business 170
7.22.3 AlveoliX Microphysiological System Products, Services and Solutions 171
7.22.4 AlveoliX Microphysiological System Revenue (US$ Million) & (2019-2024) 173
7.23 BiomimX 173
7.23.1 BiomimX Profile 173
7.23.2 BiomimX Main Business 174
7.23.3 BiomimX Microphysiological System Products, Services and Solutions 174
7.23.4 BiomimX Microphysiological System Revenue (US$ Million) & (2019-2024) 179
7.24 Aracari Bio 179
7.24.1 Aracari Bio Profile 179
7.24.2 Aracari Bio Main Business 180
7.24.3 Aracari Bio Microphysiological System Products, Services and Solutions 180
7.24.4 Aracari Bio Microphysiological System Revenue (US$ Million) & (2019-2024) 182
7.25 StemPharm 182
7.25.1 StemPharm Profile 183
7.25.2 StemPharm Main Business 183
7.25.3 StemPharm Microphysiological System Products, Services and Solutions 184
7.25.4 StemPharm Microphysiological System Revenue (US$ Million) & (2019-2024) 185
7.26 SynVivo 185
7.26.1 SynVivo Profile 185
7.26.2 SynVivo Main Business 186
7.26.3 SynVivo Microphysiological System Products, Services and Solutions 187
7.26.4 SynVivo Microphysiological System Revenue (US$ Million) & (2019-2024) 188
8 Industry Chain Analysis 190
8.1 Microphysiological System Industrial Chain 190
8.2 Whole Industry Chain Map 191
8.3 Microphysiological System Upstream Analysis 191
8.3.1 Upstream Analysis 191
8.3.2 Raw Materials Key Suppliers 192
8.3.3 Manufacturing Cost Structure 193
8.4 Downstream Analysis (Customers Analysis) 194
8.5 Main Business Model 195
8.6 Sales Model and Sales Channels 197
9 Research Findings and Conclusion 200
10 Appendix 202
10.1 Research Methodology 202
10.1.1 Methodology/Research Approach 202
10.1.2 Data Source 205
10.2 Author Details 208
10.3 Disclaimer 209

　

ページTOPに戻る


　

Summary

The global market for Microphysiological System was estimated to be worth US$ 108.92 million in 2023 and is forecast to a readjusted size of US$ 706.19 million by 2030 with a CAGR of 30.3% during the forecast period 2024-2030.
North American market for Microphysiological System was valued at $ 47.54 million in 2023 and will reach $ 325.31 million by 2030, at a CAGR of 31.4 % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microphysiological System was valued at $ 12.64 million in 2023 and will reach $ 81.05 million by 2030, at a CAGR of 30.0 % during the forecast period of 2024 through 2030.
Europe market for Microphysiological System was valued at $ 44.91 million in 2023 and will reach $ 276.72 million by 2030, at a CAGR of 29.3 % during the forecast period of 2024 through 2030.

The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Hesperos, Valo Health (TARA Biosystems), TNO, AxoSim and Newcells Biotech, etc. In 2023, the global five largest players hold a share approximately 50.59 % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Microphysiological System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microphysiological System by region & country, by Type, and by End User.
The Microphysiological System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microphysiological System.

Market Segmentation

By Company
Emulate
Mimetas
InSphero
TissUse
CN Bio
Hesperos
Valo Health (TARA Biosystems)
TNO
AxoSim
Newcells Biotech
Nortis
Netri
Draper Laboratory
Beijing Daxiang Biotech
Altis Biosystems
Cherry Biotech
Bi/ond
Obatala Sciences
Ananda Devices
ImmuONE
React4life
AlveoliX
BiomimX
Aracari Bio
StemPharm
SynVivo

Segment by Type
Human Organ and Tissue Models
Disease Models
Non-Human Species Models

Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific

Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe

Latin America
Mexico
Brazil
Rest of Latin America

Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microphysiological System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Microphysiological System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Microphysiological System in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.



ページTOPに戻る


Table of Contents

1 Market Overview 1
1.1 Microphysiological System Product Introduction 1
1.2 Global Microphysiological System Market Size Forecast (2019-2030) 2
1.3 Microphysiological System Market Trends & Drivers 3
1.3.1 Microphysiological System Industry Trends 3
1.3.2 Microphysiological System Market Drivers & Opportunity 4
1.3.3 Microphysiological System Market Challenges 6
1.3.4 Microphysiological System Market Restraints 7
1.4 Government Policy Support for The Industry 8
1.5 Comparison of Related Technologies 11
1.6 Assumptions and Limitations 12
1.7 Study Objectives 13
1.8 Years Considered 14
2 Competitive Analysis by Company 15
2.1 Global Microphysiological System Players Revenue Ranking (2023) 15
2.2 Global Microphysiological System Revenue by Company (2019-2024) 16
2.3 Key Companies Microphysiological System Headquarters and Sales Area 18
2.4 Key Companies Microphysiological System Product Offered 20
2.5 Establish Date of Global Key Microphysiological System Companies 21
2.6 Microphysiological System Market Competitive Analysis 22
2.6.1 Microphysiological System Market Concentration Rate (2019-2024) 22
2.6.2 Global 5 and 10 Largest Companies by Microphysiological System Revenue in 2023 23
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2023) 24
2.7 Mergers & Acquisitions, Expansion 25
3 Segmentation by Type 31
3.1 Introduction by Type 31
3.1.1 Human Organ and Tissue Models 31
3.1.2 Disease Models 33
3.1.3 Non-Human Species Models 34
3.2 Global Microphysiological System Sales Value by Type 35
3.2.1 Global Microphysiological System Sales Value by Type (2019 VS 2023 VS 2030) 36
3.2.2 Global Microphysiological System Sales Value, by Type (2019-2030) 38
3.2.3 Global Microphysiological System Sales Value, by Type (%) (2019-2030) 38
4 Segmentation by End User 40
4.1 Introduction by End User 40
4.1.1 Pharmaceutical & Biotechnology Companies 40
4.1.2 Academic & Research Institutes 42
4.1.3 Others 43
4.2 Global Microphysiological System Sales Value by End User 44
4.2.1 Global Microphysiological System Sales Value by End User (2019 VS 2023 VS 2030) 45
4.2.2 Global Microphysiological System Sales Value, by End User (2019-2030) 47
4.2.3 Global Microphysiological System Sales Value, by End User (%) (2019-2030) 47
5 Segmentation by Region 49
5.1 Global Microphysiological System Sales Value by Region 49
5.1.1 Global Microphysiological System Sales Value by Region: 2019 VS 2023 VS 2030 49
5.1.2 Global Microphysiological System Sales Value by Region (2019-2024) 49
5.1.3 Global Microphysiological System Sales Value by Region (2025-2030) 50
5.1.4 Global Microphysiological System Sales Value by Region (%), (2019-2030) 50
5.2 North America 52
5.2.1 North America Microphysiological System Sales Value, 2019-2030 52
5.2.2 North America Microphysiological System Sales Value by Country (%), 2023 VS 2030 53
5.3 Europe 54
5.3.1 Europe Microphysiological System Sales Value, 2019-2030 54
5.3.2 Europe Microphysiological System Sales Value by Country (%), 2023 VS 2030 55
5.4 Asia Pacific 56
5.4.1 Asia Pacific Microphysiological System Sales Value, 2019-2030 56
5.4.2 Asia Pacific Microphysiological System Sales Value by Region (%), 2023 VS 2030 57
5.5 Latin America 58
5.5.1 Latin America Microphysiological System Sales Value, 2019-2030 58
5.5.2 Latin America Microphysiological System Sales Value by Country (%), 2023 VS 2030 59
5.6 Middle East & Africa 60
5.6.1 Middle East & Africa Microphysiological System Sales Value, 2019-2030 60
5.6.2 Middle East & Africa Microphysiological System Sales Value by Country (%), 2023 VS 2030 61
6 Segmentation by Key Countries/Regions 62
6.1 Key Countries/Regions Microphysiological System Sales Value Growth Trends, 2019 VS 2023 VS 2030 62
6.2 Key Countries/Regions Microphysiological System Sales Value, 2019-2030 63
6.3 United States 66
6.3.1 United States Microphysiological System Sales Value, 2019-2030 66
6.3.2 United States Microphysiological System Sales Value by Type (%), 2023 VS 2030 67
6.3.3 United States Microphysiological System Sales Value by End User, 2023 VS 2030 68
6.4 Europe 69
6.4.1 Europe Microphysiological System Sales Value, 2019-2030 69
6.4.2 Europe Microphysiological System Sales Value by Type (%), 2023 VS 2030 70
6.4.3 Europe Microphysiological System Sales Value by End User, 2023 VS 2030 71
6.5 China 72
6.5.1 China Microphysiological System Sales Value, 2019-2030 72
6.5.2 China Microphysiological System Sales Value by Type (%), 2023 VS 2030 73
6.5.3 China Microphysiological System Sales Value by End User, 2023 VS 2030 74
6.6 Japan 75
6.6.1 Japan Microphysiological System Sales Value, 2019-2030 75
6.6.2 Japan Microphysiological System Sales Value by Type (%), 2023 VS 2030 76
6.6.3 Japan Microphysiological System Sales Value by End User, 2023 VS 2030 77
6.7 Southeast Asia 78
6.7.1 Southeast Asia Microphysiological System Sales Value, 2019-2030 78
6.7.2 Southeast Asia Microphysiological System Sales Value by Type (%), 2023 VS 2030 79
6.7.3 Southeast Asia Microphysiological System Sales Value by End User, 2023 VS 2030 80
6.8 France 81
6.8.1 France Microphysiological System Sales Value, 2019-2030 81
6.8.2 France Microphysiological System Sales Value by Type (%), 2023 VS 2030 82
6.8.3 France Microphysiological System Sales Value by End User, 2023 VS 2030 83
6.9 UK 84
6.9.1 UK Microphysiological System Sales Value, 2019-2030 84
6.9.2 UK Microphysiological System Sales Value by Type (%), 2023 VS 2030 85
6.9.3 UK Microphysiological System Sales Value by End User, 2023 VS 2030 86
7 Company Profiles 87
7.1 Emulate 87
7.1.1 Emulate Profile 87
7.1.2 Emulate Main Business 88
7.1.3 Emulate Microphysiological System Products, Services and Solutions 88
7.1.4 Emulate Microphysiological System Revenue (US$ Million) & (2019-2024) 89
7.2 Mimetas 90
7.2.1 Mimetas Profile 90
7.2.2 Mimetas Main Business 90
7.2.3 Mimetas Microphysiological System Products, Services and Solutions 91
7.2.4 Mimetas Microphysiological System Revenue (US$ Million) & (2019-2024) 93
7.2.5 Mimetas Recent Developments 93
7.3 InSphero 94
7.3.1 InSphero Profile 94
7.3.2 InSphero Main Business 95
7.3.3 InSphero Microphysiological System Products, Services and Solutions 95
7.3.4 InSphero Microphysiological System Revenue (US$ Million) & (2019-2024) 96
7.3.5 InSphero Recent Developments 96
7.4 TissUse 97
7.4.1 TissUse Profile 97
7.4.2 TissUse Main Business 98
7.4.3 TissUse Microphysiological System Products, Services and Solutions 98
7.4.4 TissUse Microphysiological System Revenue (US$ Million) & (2019-2024) 99
7.5 CN Bio 99
7.5.1 CN Bio Profile 99
7.5.2 CN Bio Main Business 100
7.5.3 CN Bio Microphysiological System Products, Services and Solutions 100
7.5.4 CN Bio Microphysiological System Revenue (US$ Million) & (2019-2024) 104
7.5.5 CN Bio Recent Developments 104
7.6 Hesperos 106
7.6.1 Hesperos Profile 106
7.6.2 Hesperos Main Business 107
7.6.3 Hesperos Microphysiological System Products, Services and Solutions 107
7.6.4 Hesperos Microphysiological System Revenue (US$ Million) & (2019-2024) 109
7.7 Valo Health (TARA Biosystems) 109
7.7.1 Valo Health (TARA Biosystems) Profile 109
7.7.2 Valo Health (TARA Biosystems) Main Business 110
7.7.3 Valo Health (TARA Biosystems) Microphysiological System Products, Services and Solutions 111
7.7.4 Valo Health (TARA Biosystems) Microphysiological System Revenue (US$ Million) & (2019-2024) 112
7.7.5 Valo Health (TARA Biosystems) Recent Developments 112
7.8 TNO 113
7.8.1 TNO Profile 113
7.8.2 TNO Main Business 114
7.8.3 TNO Microphysiological System Products, Services and Solutions 114
7.8.4 TNO Microphysiological System Revenue (US$ Million) & (2019-2024) 116
7.9 AxoSim 116
7.9.1 AxoSim Profile 116
7.9.2 AxoSim Main Business 117
7.9.3 AxoSim Microphysiological System Products, Services and Solutions 118
7.9.4 AxoSim Microphysiological System Revenue (US$ Million) & (2019-2024) 119
7.9.5 AxoSim Recent Developments 119
7.10 Newcells Biotech 120
7.10.1 Newcells Biotech Profile 120
7.10.2 Newcells Biotech Main Business 121
7.10.3 Newcells Biotech Microphysiological System Products, Services and Solutions 121
7.10.4 Newcells Biotech Microphysiological System Revenue (US$ Million) & (2019-2024) 122
7.10.5 Newcells Biotech Recent Developments 123
7.11 Nortis 124
7.11.1 Nortis Profile 124
7.11.2 Nortis Main Business 125
7.11.3 Nortis Microphysiological System Products, Services and Solutions 125
7.11.4 Nortis Microphysiological System Revenue (US$ Million) & (2019-2024) 127
7.11.5 Nortis Recent Developments 127
7.12 Netri 128
7.12.1 Netri Profile 128
7.12.2 Netri Main Business 129
7.12.3 Netri Microphysiological System Products, Services and Solutions 129
7.12.4 Netri Microphysiological System Revenue (US$ Million) & (2019-2024) 131
7.12.5 Netri Recent Developments 131
7.13 Draper Laboratory 132
7.13.1 Draper Laboratory Profile 132
7.13.2 Draper Laboratory Main Business 132
7.13.3 Draper Laboratory Microphysiological System Products, Services and Solutions 133
7.13.4 Draper Laboratory Microphysiological System Revenue (US$ Million) & (2019-2024) 138
7.14 Beijing Daxiang Biotech 138
7.14.1 Beijing Daxiang Biotech Profile 138
7.14.2 Beijing Daxiang Biotech Main Business 139
7.14.3 Beijing Daxiang Biotech Microphysiological System Products, Services and Solutions 140
7.14.4 Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million) & (2019-2024) 142
7.15 Altis Biosystems 142
7.15.1 Altis Biosystems Profile 142
7.15.2 Altis Biosystems Main Business 143
7.15.3 Altis Biosystems Microphysiological System Products, Services and Solutions 144
7.15.4 Altis Biosystems Microphysiological System Revenue (US$ Million) & (2019-2024) 145
7.15.5 Altis Biosystems Recent Developments 146
7.16 Cherry Biotech 146
7.16.1 Cherry Biotech Profile 146
7.16.2 Cherry Biotech Main Business 147
7.16.3 Cherry Biotech Microphysiological System Products, Services and Solutions 148
7.16.4 Cherry Biotech Microphysiological System Revenue (US$ Million) & (2019-2024) 149
7.17 Bi/ond 149
7.17.1 Bi/ond Profile 150
7.17.2 Bi/ond Main Business 150
7.17.3 Bi/ond Microphysiological System Products, Services and Solutions 151
7.17.4 Bi/ond Microphysiological System Revenue (US$ Million) & (2019-2024) 153
7.18 Obatala Sciences 154
7.18.1 Obatala Sciences Profile 154
7.18.2 Obatala Sciences Main Business 155
7.18.3 Obatala Sciences Microphysiological System Products, Services and Solutions 155
7.18.4 Obatala Sciences Microphysiological System Revenue (US$ Million) & (2019-2024) 157
7.19 Ananda Devices 157
7.19.1 Ananda Devices Profile 157
7.19.2 Ananda Devices Main Business 158
7.19.3 Ananda Devices Microphysiological System Products, Services and Solutions 159
7.19.4 Ananda Devices Microphysiological System Revenue (US$ Million) & (2019-2024) 161
7.19.5 Ananda Devices Recent Developments 161
7.20 ImmuONE 161
7.20.1 ImmuONE Profile 162
7.20.2 ImmuONE Main Business 162
7.20.3 ImmuONE Microphysiological System Products, Services and Solutions 163
7.20.4 ImmuONE Microphysiological System Revenue (US$ Million) & (2019-2024) 165
7.20.5 ImmuONE Recent Developments 165
7.21 React4life 166
7.21.1 React4life Profile 166
7.21.2 React4life Main Business 166
7.21.3 React4life Microphysiological System Products, Services and Solutions 167
7.21.4 React4life Microphysiological System Revenue (US$ Million) & (2019-2024) 169
7.22 AlveoliX 170
7.22.1 AlveoliX Profile 170
7.22.2 AlveoliX Main Business 170
7.22.3 AlveoliX Microphysiological System Products, Services and Solutions 171
7.22.4 AlveoliX Microphysiological System Revenue (US$ Million) & (2019-2024) 173
7.23 BiomimX 173
7.23.1 BiomimX Profile 173
7.23.2 BiomimX Main Business 174
7.23.3 BiomimX Microphysiological System Products, Services and Solutions 174
7.23.4 BiomimX Microphysiological System Revenue (US$ Million) & (2019-2024) 179
7.24 Aracari Bio 179
7.24.1 Aracari Bio Profile 179
7.24.2 Aracari Bio Main Business 180
7.24.3 Aracari Bio Microphysiological System Products, Services and Solutions 180
7.24.4 Aracari Bio Microphysiological System Revenue (US$ Million) & (2019-2024) 182
7.25 StemPharm 182
7.25.1 StemPharm Profile 183
7.25.2 StemPharm Main Business 183
7.25.3 StemPharm Microphysiological System Products, Services and Solutions 184
7.25.4 StemPharm Microphysiological System Revenue (US$ Million) & (2019-2024) 185
7.26 SynVivo 185
7.26.1 SynVivo Profile 185
7.26.2 SynVivo Main Business 186
7.26.3 SynVivo Microphysiological System Products, Services and Solutions 187
7.26.4 SynVivo Microphysiological System Revenue (US$ Million) & (2019-2024) 188
8 Industry Chain Analysis 190
8.1 Microphysiological System Industrial Chain 190
8.2 Whole Industry Chain Map 191
8.3 Microphysiological System Upstream Analysis 191
8.3.1 Upstream Analysis 191
8.3.2 Raw Materials Key Suppliers 192
8.3.3 Manufacturing Cost Structure 193
8.4 Downstream Analysis (Customers Analysis) 194
8.5 Main Business Model 195
8.6 Sales Model and Sales Channels 197
9 Research Findings and Conclusion 200
10 Appendix 202
10.1 Research Methodology 202
10.1.1 Methodology/Research Approach 202
10.1.2 Data Source 205
10.2 Author Details 208
10.3 Disclaimer 209

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（demand forecast）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/19　10:28

144.64 円

160.77 円

193.27 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.